TELADOC HEALTH, INC. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
TELADOC HEALTH, INC. (TDOC) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $1.90 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-10-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2025-10-30
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-09-30 was $517.00K, a 43.99% decline year-over-year.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-06-30 was $695.00K, a 45.79% decline year-over-year.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-03-31 was $689.00K, a 54.55% decline year-over-year.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2024-12-31 was $1.03M, a 2.56% decline year-over-year.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2024 was $4.75M, a 50.80% decline from fiscal 2023.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2023 was $9.65M, a 48.45% increase from fiscal 2022.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2022 was $6.50M, a 61.33% decline from fiscal 2021.
- TELADOC HEALTH, INC. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2021 was $16.81M, a 255.99% increase from fiscal 2020.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|---|---|---|
| 2025-09-30 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $1.21M derived: sum of 2 quarters · filed 2025-10-30 | $1.90M 10-Q · filed 2025-10-30 | $2.93M derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-06-30 | $695.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.38M 10-Q · filed 2025-07-30 | $2.41M derived: sum of 3 quarters · filed 2025-07-30 | $3.33M derived: sum of 4 quarters · filed 2025-10-30 |
| 2025-03-31 | $689.00K 10-Q · filed 2025-05-01 | $1.72M derived: sum of 2 quarters · filed 2025-05-01 | $2.64M derived: sum of 3 quarters · filed 2025-10-30 | $3.92M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.95M derived: sum of 2 quarters · filed 2025-10-30 | $3.23M derived: sum of 3 quarters · filed 2025-10-30 | $4.75M 10-K · filed 2025-02-27 |
| 2024-09-30 | $923.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.21M derived: sum of 2 quarters · filed 2025-10-30 | $3.72M 10-Q · filed 2025-10-30 | $4.78M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $2.80M 10-Q · filed 2025-07-30 | $3.85M derived: sum of 3 quarters · filed 2025-07-30 | $7.01M derived: sum of 4 quarters · filed 2025-07-30 |
| 2024-03-31 | $1.52M 10-Q · filed 2025-05-01 | $2.57M derived: sum of 2 quarters · filed 2025-05-01 | $5.73M derived: sum of 3 quarters · filed 2025-05-01 | $8.44M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.22M derived: sum of 2 quarters · filed 2025-02-27 | $6.92M derived: sum of 3 quarters · filed 2025-02-27 | $9.65M 10-K · filed 2025-02-27 |
| 2023-09-30 | $3.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $5.87M derived: sum of 2 quarters · filed 2024-10-31 | $8.60M 10-Q · filed 2024-10-31 | $11.71M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.43M 10-Q · filed 2024-08-01 | $8.55M derived: sum of 3 quarters · filed 2025-02-27 | $9.96M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.73M 10-Q · filed 2024-04-26 | $5.85M derived: sum of 2 quarters · filed 2025-02-27 | $7.26M derived: sum of 3 quarters · filed 2025-02-27 | $5.55M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $4.53M derived: sum of 2 quarters · filed 2025-02-27 | $2.82M derived: sum of 3 quarters · filed 2025-02-27 | $6.50M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$294.00K derived: sum of 2 quarters · filed 2023-10-27 | $3.39M 10-Q · filed 2023-10-27 | $6.20M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $1.97M 10-Q · filed 2023-07-28 | $4.79M derived: sum of 3 quarters · filed 2024-02-23 | $7.75M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $3.68M 10-Q · filed 2023-05-02 | $6.49M derived: sum of 2 quarters · filed 2024-02-23 | $9.46M derived: sum of 3 quarters · filed 2024-02-23 | $11.84M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $5.78M derived: sum of 2 quarters · filed 2024-02-23 | $8.16M derived: sum of 3 quarters · filed 2024-02-23 | $16.81M 10-K · filed 2024-02-23 |
| 2021-09-30 | $2.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $5.35M derived: sum of 2 quarters · filed 2022-11-02 | $14.00M 10-Q · filed 2022-11-02 | $16.25M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $11.03M 10-Q · filed 2022-08-03 | $13.28M derived: sum of 3 quarters · filed 2023-03-01 | $13.28M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $8.65M 10-Q · filed 2022-05-02 | $10.90M derived: sum of 2 quarters · filed 2023-03-01 | $10.90M derived: sum of 3 quarters · filed 2023-03-01 | $13.37M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.25M derived: sum of 2 quarters · filed 2023-03-01 | $4.72M derived: sum of 3 quarters · filed 2023-03-01 | $4.72M 10-K · filed 2023-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $2.47M derived: sum of 2 quarters · filed 2021-11-01 | $2.47M 10-Q · filed 2021-11-01 | $3.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $2.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02 | $2.47M 10-Q · filed 2021-08-02 | $3.98M derived: sum of 3 quarters · filed 2022-02-28 | $3.98M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-03 | $1.50M derived: sum of 2 quarters · filed 2022-02-28 | $1.50M derived: sum of 3 quarters · filed 2022-02-28 | |
| 2019-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $1.50M derived: sum of 2 quarters · filed 2022-02-28 | $3.38M 10-K · filed 2022-02-28 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $1.88M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $1.88M 10-Q · filed 2020-07-29 | |||
| 2018-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.14M derived: sum of 2 quarters · filed 2021-03-01 | $2.56M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $1.42M 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | $1.42M 10-Q · filed 2019-07-31 | |||
| 2017-12-31 | $888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $888.00K derived: sum of 2 quarters · filed 2020-02-26 | $2.15M 10-K · filed 2020-02-26 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.26M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $1.26M 10-Q · filed 2018-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |